查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1930046

即时凝血检测设备市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测（2025-2034）

Point-of-Care Coagulation Testing Devices Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2025-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 140 Pages | 商品交期: 请询问到货日

价格

即时凝血 (POCC) 侦测设备市场成长驱动因素

由于对快速、准确的凝血评估的需求日益增长，全球即时凝血 (POCC) 检测设备市场已成为诊断技术领域的关键细分市场。这些设备使临床医生能够即时评估患者的凝血状态，从而支持在急诊、手术和抗凝血治疗监测中及时做出临床决策。

根据这份报告，预计到2025年，全球床边凝血检测设备市场规模将达20.1亿美元。预计到2026年，市场规模将扩大至21.6亿美元，到2034年将达到38.8亿美元，2026年至2034年的复合年增长率（CAGR）为7.62%。这一增长主要受出血性疾病患病率上升、床边诊断技术进步以及家庭医疗保健解决方案日益普及的推动。

市场驱动因素与成长因素

推动市场成长的关键因素之一是患有出血性疾病（例如血友病、静脉血栓栓塞和老年凝血障碍）的患者数量不断增加。人口老化使得凝血功能失衡的风险显着增加，从而推动了对便携式、易用型检测设备的需求。

此外，床边凝血检测（POC​​C）设备的技术进步显着提高了检测的准确性、易用性和出结果速度。市场参与者正在推出先进的系统，这些系统可以在医院床边或家庭医疗保健环境中快速提供检测结果。随着长期接受抗凝血治疗的患者更倾向于使用可自行操作的设备以避免频繁就医，对家庭医疗保健解决方案的需求不断增长，进一步加速了此类设备的普及。

另一个因素是新兴市场医疗保健基础设施的改善。这些国家的政府正在大力投资扩大诊断服务，尤其是在社区健康中心和小型诊所。

市场限制因素与挑战

儘管成长前景强劲，但市场仍面临诸多挑战。 POCC检测设备的高昂成本，以及持续的维护和耗材费用，限制了其在价格敏感的新兴经济体中的普及。限制性的报销政策和严格的家用检测设备监管要求也阻碍了市场渗透。

此外，与传统实验室凝血检测的竞争仍然是一大挑战，因为传统检测设备凭藉其全面的检测能力而广受信赖。医护人员对POCC设备的正确使用缺乏了解和训练不足，也可能导致POCC设备的使用率低和结果误读。

细分市场洞察

依设备类型划分，抗凝血监测设备将占市场主导地位，到2026年将占总市场占有率的79.64%。这主要归功于监管审批的增加以及在PT/INR水平监测中的广泛应用。另一方面，由于黏弹性凝血监测设备能够即时评估血栓形成的各个阶段，预计在预测期内将增长最快。

依最终用户划分，医院和诊所预计将在2026年占市场主导地位，市占率达63.85%。这主要得益于需要立即进行凝血评估的复杂外科手术数量的增加。家庭医疗保健环境领域预计将以最高的复合年增长率成长，这主要归功于患者对自我监测解决方案的偏好不断增强。

区域展望

北美将主导全球市场，到2025年将占8.5亿美元的市场占有率。这主要得益于主要製造商的强大影响力、出血性疾病的高发生率以及有利的监管批准。欧洲将占第二大市场占有率，这主要归功于医院对先进凝血分析仪的广泛应用。亚太地区预计将以最高的复合年增长率成长，这主要得益于中国、印度和日本等国家日益增强的意识、监管部门的批准以及不断扩大的医疗保健基础设施。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇

第四章：关键考虑因素

  • 主要国家主要凝血障碍盛行率（2025 年）
  • 即时检测 (POC) 凝血检测的最新进展
  • 主要国家的监管环境
  • 主要产业发展动态：併购与合作
  • 新冠疫情对市场的影响

第五章：全球即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 市场分析、洞察与预测 - 按设备类型划分
    • 抗凝血监测设备
      • 凝血酶原时间/国际标准化比值 (PT-INR) 测量设备
      • 活化凝血时间 (ACT)
      • 活化部分凝血活酶时间 (aPTT)
    • 血小板功能监测设备
    • 黏弹性凝血监测设备
      • 血栓弹力图 (TEG)
      • 旋转血栓弹力图 (ROTEM)
    • 其他
  • 市场分析、洞察与预测 - 按最终用户划分
    • 医院和诊所
    • 家庭医疗保健
    • 其他
  • 市场分析、洞察与预测 - 按地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 美国王国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第八章 亚太地区即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 依国家/地区
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东和非洲即时凝血检测设备市场分析、洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会国家
    • 南非
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2025）
  • 公司简介
    • Werfen
    • CoaguSense Inc.
    • Helena Laboratories Corporation
    • Medtronic
    • Abbott
    • F.霍夫曼-拉罗氏有限公司
    • 西门子医疗保健股份公司
    • Koninklijke Philips N.V.
    • HemoSonics LLC
    • Haemonetics 公司
Product Code: FBI101235

Growth Factors of point-of-care coagulation (POCC) testing devices Market

The global point-of-care coagulation (POCC) testing devices market has emerged as a critical segment within diagnostic technologies due to the increasing need for rapid and accurate coagulation assessment. These devices enable clinicians to evaluate a patient's coagulation status in real time, supporting timely clinical decisions in emergency care, surgical procedures, and anticoagulation therapy monitoring.

According to the report, the global POCC testing devices market was valued at USD 2.01 billion in 2025. The market is projected to expand to USD 2.16 billion in 2026 and further reach USD 3.88 billion by 2034, registering a compound annual growth rate (CAGR) of 7.62% during the forecast period from 2026 to 2034. This growth is primarily driven by the rising prevalence of bleeding disorders, technological advancements in point-of-care diagnostics, and increasing adoption of home-based healthcare solutions.

Market Drivers and Growth Factors

One of the key drivers fueling market growth is the increasing patient pool suffering from bleeding disorders, including hemophilia, venous thromboembolism, and coagulation abnormalities associated with aging. The growing geriatric population is particularly vulnerable to coagulation imbalance, thereby increasing demand for portable and easy-to-use testing devices.

In addition, technological advancements in POCC testing devices have significantly improved accuracy, usability, and turnaround time. Market players are launching advanced systems capable of delivering rapid results at the bedside or in homecare settings. The rising demand for home healthcare solutions has further accelerated adoption, as patients undergoing long-term anticoagulation therapy prefer self-monitoring devices to avoid frequent hospital visits.

Another contributing factor is the improvement in healthcare infrastructure in emerging markets, where governments are investing heavily in expanding diagnostic services, especially in community healthcare centers and small clinics.

Market Restraints and Challenges

Despite strong growth prospects, the market faces notable challenges. The high cost of POCC testing devices, along with recurring expenses related to maintenance and consumables, restricts adoption in price-sensitive and emerging economies. Limited reimbursement policies and stringent regulatory requirements for home-based testing devices also hinder market penetration.

Furthermore, competition from traditional laboratory coagulation testing remains a challenge, as conventional analyzers are widely trusted for their comprehensive testing capabilities. A lack of awareness and insufficient training among healthcare professionals regarding the correct use of POCC devices can also lead to underutilization and misinterpretation of results.

Segmentation Insights

By device type, anticoagulation monitoring devices dominated the market, accounting for 79.64% of the total market share in 2026, supported by increasing regulatory approvals and widespread use in monitoring PT/INR levels. Meanwhile, viscoelastic coagulation monitoring devices are expected to witness the fastest growth during the forecast period due to their ability to assess all stages of clot formation in real time.

By end user, the hospitals and clinics segment led the market with a 63.85% share in 2026, driven by the growing number of complex surgical procedures requiring immediate coagulation assessment. The homecare settings segment is anticipated to grow at the highest CAGR due to rising patient preference for self-monitoring solutions.

Regional Outlook

North America dominated the global market in 2025, accounting for USD 0.85 billion, supported by the strong presence of leading manufacturers, high prevalence of bleeding disorders, and favorable regulatory approvals. Europe held the second-largest share due to the introduction of advanced coagulation analyzers in hospitals. The Asia Pacific region is expected to grow at the highest CAGR, driven by increasing awareness, regulatory approvals, and expanding healthcare infrastructure in countries such as China, India, and Japan.

Competitive Landscape

The market is semi-consolidated, with major players including F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers AG, Werfen, Haemonetics Corporation, and Medtronic. These companies focus on strategic collaborations, regulatory approvals, and product innovations to strengthen their market position.

Conclusion

In conclusion, the global point-of-care coagulation (POCC) testing devices market is poised for sustained growth, rising from USD 2.01 billion in 2025 to USD 3.88 billion by 2034. The increasing burden of bleeding disorders, growing demand for rapid diagnostic solutions, and expansion of home-based healthcare are key factors shaping market expansion. While high costs and competition from traditional laboratory testing pose challenges, ongoing technological advancements and strategic initiatives by leading players are expected to enhance adoption and drive long-term market growth across developed and emerging regions.

Growth rate CAGR of 7.62% from 2026-2034

Segmentation

By Device Type

  • Anticoagulation Monitoring Devices
  • Prothrombin Time/International Normalized Ratio (PT/INR) Testing Devices
  • Activated Clotting Time (ACT)
  • Activated Partial Thromboplastin Time (aPTT)
  • Platelet Function Monitoring Devices
  • Viscoelastic Coagulation Monitoring Devices
  • Thromboelastography (TEG)
  • Rotational Thromboelastometry (ROTEM)
  • Others

By End User

  • Hospitals & Clinics
  • Homecare Settings
  • Others

By Region

  • North America (by Device Type, by End User, by Country)
    • U.S.
    • Canada
  • Europe (by Device Type, by End User, by Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (by Device Type, by End User, by Country/Sub-region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Latin America (by Device Type, by End User, by Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (by Device Type, by End User, by Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities

4. Key Insights

  • 4.1. Prevalence of Key Coagulation Diseases- For Key Countries, 2025
  • 4.2. Recent Advancements in the Point of Care (POC) Coagulation Testing
  • 4.3. Regulatory Scenario - For Key Countries
  • 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.5. Impact of COVID-19 on the Market

5. Global Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Device Type
    • 5.1.1. Anticoagulation Monitoring Devices
      • 5.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 5.1.1.2. Activated Clotting Time (ACT)
      • 5.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 5.1.2. Platelet Function Monitoring Devices
    • 5.1.3. Viscoelastic Coagulation Monitoring Devices
      • 5.1.3.1. Thromboelastography (TEG)
      • 5.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 5.1.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By End User
    • 5.2.1. Hospitals & Clinics
    • 5.2.2. Homecare
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Device Type
    • 6.1.1. Anticoagulation Monitoring Devices
      • 6.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 6.1.1.2. Activated Clotting Time (ACT)
      • 6.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 6.1.2. Platelet Function Monitoring Devices
    • 6.1.3. Viscoelastic Coagulation Monitoring Devices
      • 6.1.3.1. Thromboelastography (TEG)
      • 6.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 6.1.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By End User
    • 6.2.1. Hospitals & Clinics
    • 6.2.2. Homecare
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Country
    • 6.3.1. U.S.
    • 6.3.2. Canada

7. Europe Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Device Type
    • 7.1.1. Anticoagulation Monitoring Devices
      • 7.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 7.1.1.2. Activated Clotting Time (ACT)
      • 7.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 7.1.2. Platelet Function Monitoring Devices
    • 7.1.3. Viscoelastic Coagulation Monitoring Devices
      • 7.1.3.1. Thromboelastography (TEG)
      • 7.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 7.1.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By End User
    • 7.2.1. Hospitals & Clinics
    • 7.2.2. Homecare
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. U.K.
    • 7.3.2. Germany
    • 7.3.3. France
    • 7.3.4. Spain
    • 7.3.5. Italy
    • 7.3.6. Scandinavia
    • 7.3.7. Rest of Europe

8. Asia Pacific Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Device Type
    • 8.1.1. Anticoagulation Monitoring Devices
      • 8.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 8.1.1.2. Activated Clotting Time (ACT)
      • 8.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 8.1.2. Platelet Function Monitoring Devices
    • 8.1.3. Viscoelastic Coagulation Monitoring Devices
      • 8.1.3.1. Thromboelastography (TEG)
      • 8.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 8.1.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By End User
    • 8.2.1. Hospitals & Clinics
    • 8.2.2. Homecare
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. Southeast Asia
    • 8.3.6. Rest of Asia Pacific

9. Latin America Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Device Type
    • 9.1.1. Anticoagulation Monitoring Devices
      • 9.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 9.1.1.2. Activated Clotting Time (ACT)
      • 9.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 9.1.2. Platelet Function Monitoring Devices
    • 9.1.3. Viscoelastic Coagulation Monitoring Devices
      • 9.1.3.1. Thromboelastography (TEG)
      • 9.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 9.1.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By End User
    • 9.2.1. Hospitals & Clinics
    • 9.2.2. Homecare
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. Brazil
    • 9.3.2. Mexico
    • 9.3.3. Rest of Latin America

10. Middle East & Africa Point of Care (POC) Coagulation Testing Devices Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Device Type
    • 10.1.1. Anticoagulation Monitoring Devices
      • 10.1.1.1. Prothrombin Time/International Normalized Ratio (PT-INR) Testing Devices
      • 10.1.1.2. Activated Clotting Time (ACT)
      • 10.1.1.3. Activated Partial Thromboplastin Time (aPTT)
    • 10.1.2. Platelet Function Monitoring Devices
    • 10.1.3. Viscoelastic Coagulation Monitoring Devices
      • 10.1.3.1. Thromboelastography (TEG)
      • 10.1.3.2. Rotational Thromboelastometry (ROTEM)
    • 10.1.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By End User
    • 10.2.1. Hospitals & Clinics
    • 10.2.2. Homecare
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Werfen
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. CoaguSense Inc.
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Helena Laboratories Corporation
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Medtronic
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Abbott
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. F. Hoffmann-La Roche Ltd
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Siemens Healthcare AG
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Koninklijke Philips N.V.
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. HemoSonics LLC
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Haemonetics Corporation
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 22: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Device Type, 2021-2034
  • Table 27: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Anticoagulation Monitoring Devices, 2021-2034
  • Table 28: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by Viscoelastic Coagulation Monitoring Devices, 2021-2034
  • Table 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Point-of-Care Coagulation (POCC) Testing Devices Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2025 & 2034
  • Figure 3: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2025 & 2034
  • Figure 4: Global Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Region, 2025 & 2034
  • Figure 5: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 6: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 7: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 8: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 9: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country, 2025 & 2034
  • Figure 10: North America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country, 2023
  • Figure 11: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 12: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 13: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 15: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 16: Europe Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 17: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 18: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 19: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 20: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 21: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 22: Asia Pacific Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 23: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 24: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 25: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 26: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 27: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 28: Latin America Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 29: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by Device Type, 2025 & 2034
  • Figure 30: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by Device Type, 2023
  • Figure 31: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 32: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), by End-user, 2023
  • Figure 33: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 34: Middle East & Africa Point-of-Care Coagulation (POCC) Testing Devices Market Value Share (%), By Country/ Sub-region, 2023
  • Figure 35: Global Point-of-Care Coagulation (POCC) Testing Devices Market Share (%), By Company, 2023